EVALI: A Mimicker of COVID-19.

Mayo Clin Proc Innov Qual Outcomes

Division of Hospital Internal Medicine, Mayo Clinic, Rochester, MN.

Published: June 2021

AI Article Synopsis

Article Abstract

E-cigarette or vaping product use-associated lung injury (EVALI) is a respiratory illness that has significant overlap with the symptoms of coronavirus disease 2019 (COVID-19). In the current pandemic, diagnosis of EVALI may be delayed because of anchoring bias when patients present with symptoms consistent with COVID-19. We present 3 cases of patients who were hospitalized with a presumed diagnosis of COVID-19 but were later diagnosed with EVALI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006188PMC
http://dx.doi.org/10.1016/j.mayocpiqo.2021.03.002DOI Listing

Publication Analysis

Top Keywords

evali
4
evali mimicker
4
covid-19
4
mimicker covid-19
4
covid-19 e-cigarette
4
e-cigarette vaping
4
vaping product
4
product use-associated
4
use-associated lung
4
lung injury
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!